BioSpace News Archive

Alaunos Therapeutics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2023, on Wednesday, May 10, 2023, before the open of U.S. markets.

ProPhase Labs, Inc. (NASDAQ: PRPH) (“ProPhase”), a next-generation biotech, genomics and diagnostics company, today provided an update regarding its progress and development strategy for Linebacker-1 (LB-1).

Bioventus Inc. today announced that it will report financial results for the first quarter of fiscal year 2023 before the market opens on Thursday, May 11, 2023.

Delcath Systems, Inc. (Nasdaq: DCTH) announced today it will host a conference call on May 12, 2023, at 8:30 AM Eastern Time to discuss results for its first quarter ended March 31, 2023.

Precigen, Inc. today announced the Company will release first quarter 2023 financial results on Wednesday, May 10, 2023.

HeartBeam, Inc., a cardiac technology company that has developed the first and only 3D-vector electrocardiogram platform to help physicians detect heart attacks anytime, anywhere as well as diagnose other common heart conditions announced closing of its secondary offering of 16,666,666 shares of HeartBeam’s common stock.

Veracyte, Inc. (Nasdaq: VCYT) today announced that it released its inaugural Environmental, Social and Governance (ESG) Report.

Mirion (“we” or the “company”) (NYSE: MIR), a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, today announced results for the first quarter ended March 31, 2023.

Rubedo Life Sciences today announced the selection of the first-in-class development candidate RLS-1496 for the treatment of dermatological conditions using its ALEMBIC™ drug discovery platform at LSX World Conference 2023.

Society to Improve Diagnosis in Medicine announced the appointment of Ronald Wyatt, MD, MHA, as Chief Science and Medical Officer.